Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
Amid ‘Ozempic babies' questions, women account for more than 75% of young adults taking GLP-1 drugs, study finds
11:04am, Wednesday, 22'nd May 2024
More than three out of four young adults prescribed GLP-1 drugs last year were women, new research shows, raising questions about how societal views of women's weight may influence use of these medica
US FDA staff flags risk of low blood sugar for Novo Nordisk's weekly insulin
09:27am, Wednesday, 22'nd May 2024
The U.S. Food and Drug Administration's (FDA) staff on Wednesday pointed to "notable imbalance" in incidence of low blood sugar in patients with type 1 diabetes treated with Danish drugmaker Novo Nord
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
01:47pm, Tuesday, 21'st May 2024
The rivalry between Eli Lilly and Novo Nordisk extends beyond weight loss and diabetes drugs. Meanwhile, Uber has announced new features for caregivers.
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
01:34pm, Monday, 20'th May 2024
Fundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying prioritization. While the media focuses on attaining wealth, that doesn't mean much if you don't have he
Novo Nordisk weight loss drugs still showing upside risk - analyst
09:08am, Monday, 20'th May 2024
Novo Nordisk (NYSE:NVO) A/S' weight loss drug rollout continues to offer scope for upside surprises, Citi analysts have said. Despite ongoing supply constraints, four-week rolling prescription growth
Is Novo Nordisk Stock a Millionaire Maker?
02:35am, Saturday, 18'th May 2024
Novo Nordisk's already strong financials could look even better in the future as the company's drugs have loads of potential. The company's high-profit margins make it likely that earnings will soar r
Pharma Stocks Outlook: Where Are 2024's Top Performers Headed Next?
03:02pm, Friday, 17'th May 2024
The three top performing stocks discussed below have appreciated in value by an average of 129.7% in 2024. Such torrid growth logically raises the question of what is possible moving forward.
Novo Nordisk A/S - share repurchase programme
10:20am, Friday, 17'th May 2024
Bagsværd, Denmark, 17 May 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of
Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know
10:06am, Friday, 17'th May 2024
Recently, Zacks.com users have been paying close attention to Novo Nordisk (NVO). This makes it worthwhile to examine what the stock has in store.
3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
11:15am, Thursday, 16'th May 2024
Here we discuss three drugmakers, Eli Lilly and Company (LLY), Novo Nordisk (NVO) and Merck (MRK), that have raised their earnings as well as sales guidance for 2024.
Novo Resources Announces Change of Auditor
09:55am, Thursday, 16'th May 2024
VANCOUVER, British Columbia, May 16, 2024 (GLOBE NEWSWIRE) -- Novo Resources Corp. (Novo or the Company) (ASX: NVO) (TSX: NVO & NVO.WT.A) (OTCQX: NSRPF) announces that it has changed its auditors from
7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs
07:15am, Thursday, 16'th May 2024
It's no secret that artificial intelligence ( AI ) promises to transform every industry and sector, pharma included. But how do those companies plan to leverage AI, and what will it do for their stoc
Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade
06:15am, Thursday, 16'th May 2024
Several drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical companies that it alleges are trying to keep generic drugs at bay from their branded products. The Biden a
Here's Why Novo Nordisk (NVO) is a Strong Momentum Stock
10:56am, Wednesday, 15'th May 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
UK weight-loss drug price rivalry intensifies with Pharmacy2U mark-down
10:52am, Wednesday, 15'th May 2024
Britain's Pharmacy2U said on Wednesday it had cut the prices of weight-loss medication Wegovy and Mounjaro, becoming the latest in a slew of online pharmacies and slimming clinics to do so as initial
